Related Experiment Videos
Myositis non-inflammatory mechanisms: An up-dated review
Emilia Manole1,2, Alexandra E Bastian3,4, Niculina Butoianu5
1a "Victor Babes" National Institute of Pathology , Bucharest , Romania.
Journal of Immunoassay & Immunochemistry
|April 5, 2017
Summary
Idiopathic inflammatory myopathies (IIM) involve both immune and non-immune pathways. Understanding non-immune factors like endoplasmic reticulum stress and autophagy may reveal new therapeutic targets for these rare muscle diseases.
Area of Science:
- * Neurology
- * Immunology
- * Cell Biology
Background:
- * Idiopathic inflammatory myopathies (IIM) are rare, heterogeneous muscle diseases with unknown causes.
- * Current treatments are often incomplete due to diagnostic challenges and overlooked non-inflammatory factors.
- * Recent research highlights the significance of non-immune mechanisms in IIM pathology.
Purpose of the Study:
- * To review key findings on non-immune mechanisms in IIM pathogenesis.
- * To explore the correlation between inflammatory and non-inflammatory pathways in IIM.
- * To identify potential future therapeutic targets within non-immune pathways.
Main Methods:
- * Literature review of recent data on IIM pathology.
- * Analysis of non-immune mechanisms contributing to IIM.
- * Identification of emerging therapeutic targets.
Main Results:
- * Accumulated evidence points to crucial roles for non-immune factors in IIM.
- * Specific non-immune pathways implicated include endoplasmic reticulum stress, ATP metabolism, ROS generation, autophagy, and microRNA disturbances.
- * The interplay between inflammatory and non-immune mechanisms in IIM pathogenesis requires further elucidation.
Conclusions:
- * Non-immune mechanisms are integral to IIM pathology and treatment response.
- * Targeting pathways such as endoplasmic reticulum stress, ATP metabolism, ROS, autophagy, and microRNAs presents promising therapeutic avenues.
- * Further research is needed to fully understand and leverage these non-immune targets for improved IIM management.